304 related articles for article (PubMed ID: 31400577)
1. Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins.
Lawley A; Seri S; Rajabally YA
Clin Neurophysiol; 2019 Oct; 130(10):1743-1749. PubMed ID: 31400577
[TBL] [Abstract][Full Text] [Related]
2. Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?
Delmont E; Benvenutto A; Grimaldi S; Duprat L; Philibert M; Pouget J; Grapperon AM; Salort-Campana E; Sévy A; Verschueren A; Attarian S
Clin Neurophysiol; 2016 Mar; 127(3):1891-4. PubMed ID: 26750580
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the short-term effect of intravenous immunoglobulins in multifocal motor neuropathy using motor unit number index.
Philibert M; Grapperon AM; Delmont E; Attarian S
Clin Neurophysiol; 2017 Jan; 128(1):235-240. PubMed ID: 27988478
[TBL] [Abstract][Full Text] [Related]
4. Axonal loss in patients with inflammatory demyelinating polyneuropathy as determined by motor unit number estimation and MUNIX.
Paramanathan S; Tankisi H; Andersen H; Fuglsang-Frederiksen A
Clin Neurophysiol; 2016 Jan; 127(1):898-904. PubMed ID: 26049677
[TBL] [Abstract][Full Text] [Related]
5. The value of MUNIX as an objective electrophysiological biomarker of disease progression in chronic inflammatory demyelinating polyneuropathy.
Okhovat AA; Advani S; Ziaadini B; Panahi A; Salehizadeh S; Nafissi S; Haghi Ashtiani B; Rajabally YA; Fatehi F
Muscle Nerve; 2022 Apr; 65(4):433-439. PubMed ID: 35040150
[TBL] [Abstract][Full Text] [Related]
6. Peripheral nerve electrophysiology studies in relation to fatigue in patients with chronic inflammatory demyelinating polyneuropathy.
Lawley A; Abbas A; Seri S; Rajabally YA
Clin Neurophysiol; 2020 Dec; 131(12):2926-2931. PubMed ID: 32928696
[TBL] [Abstract][Full Text] [Related]
7. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
Cirillo G; Todisco V; Tedeschi G
Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Nobile-Orazio E; Cocito D; Jann S; Uncini A; Beghi E; Messina P; Antonini G; Fazio R; Gallia F; Schenone A; Francia A; Pareyson D; Santoro L; Tamburin S; Macchia R; Cavaletti G; Giannini F; Sabatelli M;
Lancet Neurol; 2012 Jun; 11(6):493-502. PubMed ID: 22578914
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
10. Changes in spatiotemporal gait parameters following intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.
Vo ML; Chin RL; Miranda C; Latov N
Muscle Nerve; 2017 Oct; 56(4):732-736. PubMed ID: 28085193
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years.
Gentile L; Mazzeo A; Russo M; Arimatea I; Vita G; Toscano A
Sci Rep; 2020 May; 10(1):7910. PubMed ID: 32404895
[TBL] [Abstract][Full Text] [Related]
12. Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes.
Breiner A; Barnett Tapia C; Lovblom LE; Perkins BA; Katzberg HD; Bril V
Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):. PubMed ID: 31454771
[TBL] [Abstract][Full Text] [Related]
13. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876
[TBL] [Abstract][Full Text] [Related]
14. A new treatment regimen with high-dose and fractioned immunoglobulin in a special subgroup of severe and dependent CIDP patients.
Debs R; Reach P; Cret C; Demeret S; Saheb S; Maisonobe T; Viala K
Int J Neurosci; 2017 Oct; 127(10):864-872. PubMed ID: 27918219
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.
Merkies ISJ; van Schaik IN; Léger JM; Bril V; van Geloven N; Hartung HP; Lewis RA; Sobue G; Lawo JP; Durn BL; Cornblath DR; De Bleecker JL; Sommer C; Robberecht W; Saarela M; Kamienowski J; Stelmasiak Z; Tackenberg B; Mielke O;
J Peripher Nerv Syst; 2019 Mar; 24(1):48-55. PubMed ID: 30672091
[TBL] [Abstract][Full Text] [Related]
16. Optimization of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy evaluated by grip strength measurement.
Kokubun N; Sada T; Yuki N; Okabe M; Hirata K
Eur Neurol; 2013; 70(1-2):65-9. PubMed ID: 23796651
[TBL] [Abstract][Full Text] [Related]
17. IVIG regulates BAFF expression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
Ritter C; Förster D; Albrecht P; Hartung HP; Kieseier BC; Lehmann HC
J Neuroimmunol; 2014 Sep; 274(1-2):225-9. PubMed ID: 25002077
[TBL] [Abstract][Full Text] [Related]
18. Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Afzal S
J Neurol; 2019 Feb; 266(2):461-467. PubMed ID: 30556098
[TBL] [Abstract][Full Text] [Related]
19. Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; van den Berg LH; Vermeulen M; Brusse E; Cats EA; van der Kooi AJ; Notermans NC; van der Pol WL; van Schaik IN; van Nes SI; Hop WC; van Doorn PA
J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1374-9. PubMed ID: 20587484
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
